- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05480852
Clinical Performance of BIS-GMA Free Dental Resin Composite
Clinical Performance of BIS-GMA Free Dental Resin Composite as Posterior Restoration: a Randomized Clinical Trial
Resin composites were introduced for restoring defective teeth commercially in the mid- 1960s as an alternative to acrylic resin and silicate cements. As one of the most significant contributions to dentistry, dental resin composites usually have three components as organic resin matrix, photo initiator system, and coupling agent treated inorganic fillers.
At present, the most commonly used organic resin matrix for dental resin composites are based on di-methacrrylates such as 2.2- bis [p-(2- hydroxy-3- methacryloxypropoxy) penylene] propane (Bis-GMA), ethoxylated bisGMA, 1,6-bis(2-methacryloyoxy-ethoxycarbonyl-amino)-2,4,4tri-methyl-hexane (UDMA) and triethyleneglycoldimethacrylate (TEGDMA).
The application of Bis-GMA has been doubted since it was reported to have estrogenic activity in a cell culture assay.Though later studies have showed that Bis-GMA does not hydrolyse into the estrogenic substance BPA, BPA has still been detected to be release out of several commercial Bis-GMA-based dental restorative materials. Although there is a lack of studies analysing the association between BPA exposure from dental materials and its adverse effects on human health, there is a need to develop newer BPA-free resin composites to minimize human exposure to this compound. Accordingly, the objective of this study was to evaluate the performance of BIS- GMA- free composite as a photopolymerizable posterior dental composite restoration.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Hypothesis: The null hypothesis is that there is no difference in using the new BIS- GMA- free composite.
Aim of the study: This clinical trial was conducted to compare the clinical performance of the new BIS- GMA- free composite versus BIS-GMA- containing composite in the management of carious lesion in adult patients over 9 months. The two types of composites will be evaluated using USPHS criteria for:
- Retention (R).
- Contact (C).
- Color match (CM).
- Marginal adaptation (MA).
- Marginal discoloration (MD).
- Anatomic form (AF).
- Secondary caries (SC).
- Surface texture (ST).
- Gingival inflammation (GI).
- Post-operative sensitivity (POS).
- Patient complaints (PC).
- Patient satisfaction (PS).
- The evaluation done by three calibrated operators.
The study was conducted in Operative Dentistry Department, Faculty of Dentistry, Menia University.
The researcher was bear ultimate responsibility for all activities associated with the conduct of a research project including recruitment of patients, explaining, and performing the procedures to them.
- Intervention:
BIS- GMA- free composite material:
Tooth preparation and restoration was carried out using magnifying loops. All cavities were restored using composite resin. cavities, including the dentin, were acid etched for 30 s, rinsed thoroughly for 15 s, bonded with universal adhesive and light cured for 10 s prior to placing the filling material.
Restorations were light cured for 20 s, check the occlusion, finished with diamond burs and polished with Kenda hybrid composite pre- and super-polishers (Kenda, Vaduz, Liechtenstein).
- Comparator:
BIS- GMA- containing composite material:
The same methodology of the intervention BIS-GMA- free composite material If the patient showed any complications during our clinical trial toward either the intervention (BIS- GMA- free composite) or the comparator (BIS-GMA containing composite material), the trial will be stopped at once and all the needed management against any complications will be done.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Minya, Egypt, 61511
- Sara Ahmed Reda Mohamed
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Have been from 20 to 45 years of age.
- Have at least two molars supported permanent dentition free of any clinically significant occlusal interference who required class I or class II restoration and fulfilled the inclusion criteria, will informed about the study and will give a patient information leaflet (PIL) describing their potential involvement.
- The two studied materials restorations should be used in approximately the same sized lesions or within the same extension.
- The patient will be reimbursed for attending for the clinical evaluation(s) of their restorations.
- Be a regular dental attender who agree to return for assessments.
Exclusion Criteria:
- There was a history of any adverse reaction to clinical materials of the type to be used in the study.
- There was evidence of occlusal parafunction and/or pathological tooth wear.
- patients whose history revealed parafunctional habits or use of medications that potentially could cause hyposalivation.
- They are pregnant or have medical and/or dental histories which could possibly complicate their attendance for the assessment of the restorations and/ or influence the behavior and performance of the restorations in the clinical service.
- They were irregular dental attenders.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Bis-GMA Free dental resin composite
Restorative Materials
|
Restorative Material
|
Active Comparator: Bis-GMA containing dental resin composite
Restorative Materials
|
Restorative Material
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluate the performance of BIS- GMA- free composite as a photopolymerizable posterior dental composite restoration versus BIS-GMA containing composite.
Time Frame: 9 months
|
This clinical trial conducted to compare the clinical performance of the new BIS- GMA- free composite versus BIS-GMA- containing composite in the management of carious lesion in adult patients over 9 months.
The two types of composites will be evaluated using USPHS criteria
|
9 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sara A Reda, Phd, Faculty of Dentistry, Minia University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Faculty of Dentistry
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Therapeutics
-
Universidade do Vale do ParaíbaCompleted
-
University of New MexicoCompleted
-
Medical University of LodzCompletedPeriodontitis | Therapeutics | Fatty Acids, UnsaturatedPoland
-
Lao-Oxford-Mahosot Hospital Wellcome Trust Research...Mahidol Oxford Tropical Medicine Research UnitNot yet recruitingInfectious Disease | TherapeuticsLao People's Democratic Republic
-
Mayo ClinicCompletedTelemedicine | Primary Health Care | Diagnosis | Therapeutics | Developing CountriesHonduras
-
Fundação de Medicina Tropical Dr. Heitor Vieira...Oswaldo Cruz Foundation; Ministry of Health, BrazilCompletedMalaria, Vivax | TherapeuticsBrazil
-
Tianjin Anding HospitalCompletedSchizophrenia | Therapeutics
-
Peking Union Medical CollegeUnknownBreast Neoplasm Female | Mutation | TherapeuticsChina
-
Lille Catholic UniversityAllerganUnknownJoint Diseases | Magnetic Resonance Imaging | Knee | TherapeuticsFrance
-
University of Colorado, DenverPurdue University; Human Animal Bond Institute for ResearchCompletedAutism Spectrum Disorder | Child Behavior | Psychiatric Hospitalization | Veterinary Therapeutics
Clinical Trials on Bis-GMA Free dental resin composite
-
Nuh Naci Yazgan UniversityTC Erciyes UniversityCompleted
-
Faculty Sao Leopoldo Mandic CampinasUnknownDental Caries in ChildrenBrazil
-
Faculty Sao Leopoldo Mandic CampinasUnknownDental Caries in ChildrenBrazil
-
Karolinska InstitutetPublic Dental Health Service in Stockholm ABRecruiting
-
Faculty Sao Leopoldo Mandic CampinasCompleted
-
Universidade do Vale do SapucaiCompletedRestored Decayed Teeth and Post-operative SensitivityBrazil
-
Cairo UniversityNot yet recruitingClinical Performance
-
University of AthensUnknownNon-carious Cervical Lesions | Adhesive PerformanceGreece
-
Aydin Adnan Menderes UniversityCompleted
-
Orthovita d/b/a StrykerUnknownSpinal FracturesUnited States